UP!

VRNS $47.31

VRNS target price
47.31
0
0
Varonis Systems
Type
Public
Traded as NASDAQ: VRNS
Industry Computer software
Founded 2004
Founder Yaki Faitelson
Ohad Korkus
Headquarters New York City, U.S.
Area served
Worldwide
Key people
Yaki Faitelson
(CEO)
Ohad Korkus
(Chief Technology Officer)
Revenue
  • US$ 164.5 million (2016)
Total assets
  • US$ 181.8 million (2016)
Total equity
  • US$ 82.7 million (2016)
Number of employees
1000 (2017)
Website http://varonis.com

Varonis Systems is an American software company with headquarters in New York City with R&D offices in Herzliya, Israel. They developed a security software platform to let organizations track, visualize, analyze and protect their unstructured data. Varonis performs User Behavior Analytics (UBA) to identify abnormal behavior and defend enterprise data from cyberattacks. Their software extracts metadata from an enterprise’s IT infrastructure and uses this information to map relationships among employees, data objects, content, and usage - giving organizations more visibility into their data, and protecting their critical and sensitive information.

Varonis Systems was founded in 2005 by Yaki Faitelson and Ohad Korkus, in order to address security issues such as file activity tracking, information rights management, and access control. Prior to Varonis, Mr. Faitelson and Mr. Korkus held leadership positions in the global professional services and systems integration divisions of NetVision and NetApp.

In 2003, a number of critical files - expensive, high res images of the ocean floor - disappeared suddenly from the file servers where they were stored. The energy company that had spent millions of dollars to create those images wanted to know who deleted the files, and who had access to the folders holding the files. Storage experts Faitelson and Korkus quickly realized that there were no existing systems able to answer these questions, and founded Varonis in order to create a better way to protect, track, analyze, and visualize data.

Faitelson and Korkus invented a solution that would retrieve metadata contained in file systems. They brought in Dr. Jacob Goldberger, an expert in statistical modeling and machine learning, to help develop the algorithms that would provide the user-data link. In 2005, Faitelson, Goldberger, and Korkus filed a patent, “Automatic management of storage access control, which was granted in 2006. The result of their work was the Intelligent Data Use (IDU) classification platform, a platform for gathering and analyzing file data use. The first product based on this platform, DatAdvantage, was released in 2006 - built so that enterprises can monitor file activity and user behavior, and manage data ownership, data access rights, and responsibilities of file system data.

Varonis continued with core platform development. In 2009, Varonis added the IDU Classification Framework, which allowed Varonis products to search for keywords, phrases and patterns from file content. In 2013, Varonis released DatAlert to detect and uncover insider threats and potential data breaches, notifying and alerting on suspicious file system activity including unusual access to sensitive data and changes to permissions and configuration files.

Varonis raised capital from Accel Partners, Evergreen Venture Partners, Gitano Venture Capital, and EMC. On February 28, 2014 an initial public offering of Varonis stock raised about $106 million.

The Varonis Metadata Framework is implemented at two levels. Non-intrusive monitoring resides on file servers, feeding both real-time file event information and ACLs to a separate server. The collected data is stored in a database. The second part, the IDU analytics engine, performs statistical analysis to derive data owners, baseline user activity, and user groupings. The Metadata Framework is able to incrementally index file metadata, thereby allowing it to efficiently maintain the current state of file metadata in its database. DatAdvantage presents this information to IT administrators. As of April 30, 2016, Varonis had 28 issued patents in the United States and 43 pending U.S. patent applications.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2022 2022-10-31 Future report Set alerts
Q2 2022 2022-08-01 0.00 0.00
Q1 2022 2022-05-02 -0.09 -0.09
Q4 2021 2022-02-07 0.16 0.16
Q3 2021 2021-11-01 0.05 0.05
Q2 2021 2021-08-02 -0.01 -0.01
Q1 2021 2021-05-03 -0.08 -0.08
Q4 2020 2021-02-08 0.34 0.34
Q3 2020 2020-10-26 0.00 0.00
Q2 2020 2020-08-03 -0.15 -0.77

Ratings

2016-07-05 Reiterated Rating Jefferies Group Buy
2016-06-30 Reiterated Rating Summit Redstone Buy $30.00
2016-06-25 Reiterated Rating Brean Capital Buy $35.00
2016-06-10 Reiterated Rating Brean Capital Buy
2016-05-16 Boost Price Target Imperial Capital Outperform $26.00 to $27.00
2016-05-07 Reiterated Rating Jefferies Group Buy $25.00 to $26.00
2016-05-02 Reiterated Rating Brean Capital Buy $25.00
2016-04-28 Boost Price Target Stephens Overweight $20.00 to $24.00
2016-03-17 Boost Price Target Barclays Equal Weight $17.00 to $20.00
2016-03-17 Boost Price Target Barclays PLC Equal Weight $17.00 to $20.00
2016-02-14 Reiterated Rating Brean Capital Buy
2016-02-10 Lower Price Target Barclays Equal Weight $19.00 to $17.00
2016-02-08 Initiated Coverage Brean Capital Buy $25.00
2016-02-08 Lower Price Target RBC Capital $26.00 to $22.00
2016-02-08 Lower Price Target Royal Bank Of Canada $26.00 to $22.00
2016-01-12 Initiated Coverage Brean Capital Buy $25.00
2015-12-16 Initiated Coverage Lake Street Capital Buy $25.00
2015-11-12 Lower Price Target Imperial Capital Outperform $30.00 to $26.00
2015-10-09 Lower Price Target Barclays $24.00 to $19.00
2015-09-29 Initiated Coverage Stifel Nicolaus Hold
2015-09-10 Downgrade Morgan Stanley Equal Weight to Underweight $24.00 to $16.00
2015-08-07 Lower Price Target Jefferies Group Buy $35.00 to $30.00
2015-05-10 Reiterated Rating RBC Capital Outperform $43.00 to $26.00
2015-05-07 Lower Price Target JMP Securities Market Outperform $40.00 to $34.00
2015-05-07 Lower Price Target Barclays Equal Weight $35.00 to $24.00
2015-05-07 Lower Price Target Jefferies Group Buy $45.00 to $35.00
2015-05-07 Downgrade Needham & Company LLC Buy to Hold
2015-02-18 Boost Price Target Barclays Equal Weight $34.00 to $35.00
2015-02-18 Boost Price Target Jefferies Group Buy $38.00 to $45.00
2015-02-18 Boost Price Target Needham & Company LLC Buy $40.00 to $42.00
2015-02-12 Boost Price Target Imperial Capital Outperform $30.00 to $41.00
2015-01-20 Boost Price Target Needham & Company LLC Buy $25.00 to $40.00
2015-01-13 Boost Price Target JMP Securities Outperform $30.00 to $40.00
2015-01-07 Initiated Coverage Stephens Overweight
2015-01-06 Downgrade Barclays Overweight to Equal Weight $31.00 to $34.00
2014-12-19 Boost Price Target Jefferies Group Buy $30.00 to $35.00
2014-12-15 Initiated Coverage Summit Research Buy
2014-11-21 Initiated Coverage Jefferies Group Buy $30.00
2014-11-07 Reiterated Rating Barclays Overweight $34.00 to $31.00
2014-10-02 Initiated Coverage JMP Securities Outperform $30.00
2014-09-04 Boost Price Target Barclays Overweight $32.00 to $34.00
2014-05-23 Lower Price Target Barclays Overweight $42.00 to $32.00
2014-05-12 Lower Price Target Imperial Capital Outperform $35.00 to $30.00
2014-05-06 Lower Price Target Needham & Company LLC $48.00 to $45.00
2014-05-06 Lower Price Target RBC Capital $50.00 to $43.00
2014-05-06 Lower Price Target Jefferies Group Buy $45.00 to $38.00
2014-04-22 Initiated Coverage Imperial Capital Outperform $35.00
2014-04-11 Upgrade Barclays Equal Weight to Overweight $42.00
2014-03-25 Initiated Coverage Needham & Company LLC Buy $48.00
2014-03-25 Initiated Coverage Jefferies Group Buy $45.00
2014-03-25 Initiated Coverage Morgan Stanley Equal Weight
2014-03-25 Initiated Coverage Barclays Buy to Equal Weight $42.00
2014-03-25 Initiated Coverage RBC Capital Outperform $50.00
2016-07-05 Reiterated Rating Jefferies Group Buy
2016-06-30 Reiterated Rating Summit Redstone Buy $30.00
2016-06-25 Reiterated Rating Brean Capital Buy $35.00
2016-06-10 Reiterated Rating Brean Capital Buy
2016-05-16 Boost Price Target Imperial Capital Outperform $26.00 to $27.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Shachar Erez 15.36%  (3762799) VRNS /
Pitango Venture Capital Principals Fund IV, L.P. 13.33%  (3265465) VRNS /
EVERGREEN IV L.P. 10.95%  (2681389) VRNS /
EMC CORP 4.97%  (1217354) EMC / VMW / VRNS /
J.P. Morgan Digital Growth Fund L.P. 3.48%  (852974) SALE / VRNS /
JPMorgan Direct Venture Capital Institutional Investors IV LLC 3.34%  (818854) VRNS /
Melamed Guy Chief Financial Officer 0.54%  (131306) VRNS /
Bass David EVP Engineering & CTO 0.52%  (127250) VRNS /
COMOLLI KEVIN E 0.34%  (82931) VRNS /
Mann Eric Chief Operating Officer 0.32%  (77164) NMBL / VRNS /
Pitango Venture Capital Fund IV, L.P. 0.23%  (56206) VRNS /
Iohan Gili Chief Financial Officer 0.21%  (52399) VRNS /
VAN DEN BOSCH FRED 0.16%  (40177) VRNS /
GAVIN JOHN J JR 0.16%  (40177) BSFT / NAVI / QLIK / VPRT / VRNS /
ACCEL EUROPE ASSOCIATES LLC 0.14%  (34379) VRNS /
Korkus Ohad Chief Technology Officer 0.12%  (30457) VRNS /
J.P. Morgan Investment Management Inc. 0.09%  (21595) SALE / VRNS /
O'Boyle James SVP of Worldwide Sales 0.09%  (21000) VRNS /
Segev Ofer 0.08%  (18796) VRNS /
MENDOZA THOMAS F 0.07%  (18203) SREV / VRNS /
Segev-Gal Rona 0.06%  (15107) VRNS /